We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
376
Palantir
PLTR
$411B
$258K 0.01%
15,000
-22,500
-60% -$401K
QQQ icon
377
PUT
Invesco QQQ Trust
QQQ
$483B
$252K 0.01%
+90,000
New +$34.2M
GLUE icon
378
Monte Rosa Therapeutics
GLUE
$1.35B
$250K 0.01%
44,247
-41,231
-48% -$162K
ALKS icon
379
Alkermes
ALKS
$8.29B
$244K 0.01%
+8,794
New +$228K
BCYC
380
CALL
Bicycle Therapeutics
BCYC
$295M
$226K 0.01%
125,000
+101,500
+432% +$1.68M
BKD icon
381
Brookdale Senior Living
BKD
$3.4B
$222K 0.01%
+38,166
New +$179K
KRG icon
382
Kite Realty
KRG
$5.35B
$208K 0.01%
+9,102
New +$194K
UBX
383
DELISTED
Unity Biotechnology
UBX
$179K 0.01%
92,700
-86,380
-48% -$161K
HLN icon
384
Haleon
HLN
$44.2B
$177K 0.01%
21,500
-52,685
-71% -$434K
MAT icon
385
CALL
Mattel
MAT
$4.27B
$170K 0.01%
+172,500
New +$3.36M
BGS icon
386
PUT
B&G Foods
BGS
$282M
$160K 0.01%
225,000
+10,000
+5% +$92.6K
AFMD
387
DELISTED
Affimed
AFMD
$159K 0.01%
25,494
-56,506
-69% -$234K
CPRI icon
388
PUT
Capri Holdings
CPRI
$1.74B
$142K ﹤0.01%
13,900
ARGX icon
389
CALL
argenx
ARGX
$54.3B
$135K ﹤0.01%
+12,000
New +$5.59M
IWM icon
390
CALL
iShares Russell 2000 ETF
IWM
$83B
$128K ﹤0.01%
30,000
-10,000
-25% -$1.79M
APLS
391
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$119K ﹤0.01%
25,000
-25,000
-50% -$1.27M
PTCT icon
392
CALL
PTC Therapeutics
PTCT
$6.09B
$119K ﹤0.01%
+50,000
New +$1.14M
ADT icon
393
PUT
ADT
ADT
$5.6B
$116K ﹤0.01%
35,600
KVUE icon
394
CALL
Kenvue
KVUE
$37B
$116K ﹤0.01%
+130,000
New +$2.6M
HOG icon
395
PUT
Harley-Davidson
HOG
$2.72B
$100K ﹤0.01%
250,000
SWTX
396
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$99K ﹤0.01%
+30,000
New +$783K
CONXW
397
DELISTED
CONX Corp. Warrant
CONXW
$98.6K ﹤0.01%
316,890
-143,328
-31% -$31.9K
DTIL icon
398
Precision BioSciences
DTIL
$205M
$86.9K ﹤0.01%
7,937
-36,673
-82% -$395K
MRNA icon
399
CALL
Moderna
MRNA
$23.4B
$85.5K ﹤0.01%
+12,000
New +$1.01M
NBIX icon
400
CALL
Neurocrine Biosciences
NBIX
$16.7B
$85K ﹤0.01%
+10,000
New +$1.15M

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.